1. Home
  2. ESPR vs RICK Comparison

ESPR vs RICK Comparison

Compare ESPR & RICK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ESPR
  • RICK
  • Stock Information
  • Founded
  • ESPR 2008
  • RICK 1983
  • Country
  • ESPR United States
  • RICK United States
  • Employees
  • ESPR N/A
  • RICK N/A
  • Industry
  • ESPR Biotechnology: Pharmaceutical Preparations
  • RICK Restaurants
  • Sector
  • ESPR Health Care
  • RICK Consumer Discretionary
  • Exchange
  • ESPR Nasdaq
  • RICK Nasdaq
  • Market Cap
  • ESPR 456.6M
  • RICK 417.5M
  • IPO Year
  • ESPR 2013
  • RICK 1995
  • Fundamental
  • Price
  • ESPR $2.52
  • RICK $51.68
  • Analyst Decision
  • ESPR Buy
  • RICK Strong Buy
  • Analyst Count
  • ESPR 3
  • RICK 1
  • Target Price
  • ESPR $8.17
  • RICK $98.00
  • AVG Volume (30 Days)
  • ESPR 5.2M
  • RICK 79.1K
  • Earning Date
  • ESPR 11-07-2024
  • RICK 12-12-2024
  • Dividend Yield
  • ESPR N/A
  • RICK 0.54%
  • EPS Growth
  • ESPR N/A
  • RICK N/A
  • EPS
  • ESPR N/A
  • RICK 0.53
  • Revenue
  • ESPR $295,451,000.00
  • RICK $297,620,000.00
  • Revenue This Year
  • ESPR $198.22
  • RICK $2.54
  • Revenue Next Year
  • ESPR $25.83
  • RICK $7.02
  • P/E Ratio
  • ESPR N/A
  • RICK $97.99
  • Revenue Growth
  • ESPR 187.12
  • RICK 2.66
  • 52 Week Low
  • ESPR $1.16
  • RICK $37.61
  • 52 Week High
  • ESPR $3.40
  • RICK $69.40
  • Technical
  • Relative Strength Index (RSI)
  • ESPR 64.07
  • RICK 70.31
  • Support Level
  • ESPR $2.02
  • RICK $47.97
  • Resistance Level
  • ESPR $2.60
  • RICK $52.47
  • Average True Range (ATR)
  • ESPR 0.19
  • RICK 1.74
  • MACD
  • ESPR 0.02
  • RICK 0.12
  • Stochastic Oscillator
  • ESPR 89.04
  • RICK 92.09

About ESPR Esperion Therapeutics Inc.

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The Company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.

About RICK RCI Hospitality Holdings Inc.

RCI Hospitality Holdings Inc through its subsidiaries owns and operates establishments that offer live adult entertainment, restaurant, and or bar operations. It also owns and operates a communication company serving the adult nightclubs industry. The company's operating business segments are Nightclubs, Bombshells, and Others. It operates nightclubs through the following brand's Rick's Cabaret, Vivid Cabaret, Tootsie's Cabaret, Club Onyx, and Jaguars Club. In the Bombshells segment, the company is building a chain of Restaurants and Sports Bars in Dallas, Austin, and Houston, Texas. It derives majority revenue from the Nightclubs segment that engages in the sale of alcoholic beverages, food, and merchandise items; service in the form of cover charge, dance fees, and room rentals.

Share on Social Networks: